MINNEAPOLIS--(BUSINESS WIRE)--June 29, 2006--Raymedica today announced that it has received FDA approval to begin enrolling patients in a US clinical study to evaluate the potential benefits of its HydraFlex(TM) Nucleus Arthroplasty System(TM), a new non-fusion technology for the treatment of degenerative disc disease.
